Contraindicated (1)pentobarbital will decrease the level or influence of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is accountable for the development and elimination of cariprazine's active metabolites.pentobarbital will minimize the level or impact of lonafarnib by impacting hepatic/intestinal en